Introducing Unnatural Amino Acids-Containing Tripeptides as Antimicrobial and Anticancer Agents
Hydrogelators are crosslinked polymeric networks that are capable of holding large amounts of water by surface tension. High-water absorption capacity makes hydrogels readily biocompatible and, thus, more attractive for medical applications. The objective of the present in vitro
study was to test supramolecular hydrogelators for multiple biomedical applications: bacterial- and cancer-related diseases. Four naphthalene-tripeptides and their D-enantiomers were synthesized using an Fmoc Solid Phase Peptide Synthesis strategy and were tested for their activity on normal
and cancer cells as well as bacteria. Here, the D-enantiomer of alanine containing tripeptides at a concentration of 0.25 wt% inhibited the growth of Staphylococcus epidermidis. Moreover, cytotoxicity assays showed that naphthalene containing tripeptides possessing α-aminoisobutyric
acid (Aib, U) between the two phenylalanine groups (i.e., NapFUF) selectively decreased against melanoma cancer cell viability at 0.25 wt% compared to controls (no additives) over a 24 h time period. These results suggest, for the first time, that naphthalene-tripeptides containing α-aminoisobutyric
acid or alanine have numerous potential uses for diverse medical applications, in particular for fighting cancer and bacterial infections.
Keywords: ANTIMICROBIAL PEPTIDES; HYDROGELATORS; MELANOMA CELLS; SELF-ASSEMBLED; STAPHYLOCOCCUS EPIDERMIDIS
Document Type: Research Article
Publication date: 01 May 2018
- Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content